BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19569232)

  • 21. E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer.
    de Lima JM; de Souza LG; da Silva ID; Forones NM
    Int J Biol Markers; 2009; 24(2):99-106. PubMed ID: 19634113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21.
    Curtin K; Lin WY; George R; Katory M; Shorto J; Cannon-Albright LA; Bishop DT; Cox A; Camp NJ;
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):616-21. PubMed ID: 19155440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis.
    Deng QW; He BS; Pan YQ; Sun HL; Xu YQ; Gao TY; Li R; Song GQ; Wang SK
    Asian Pac J Cancer Prev; 2014; 15(8):3705-13. PubMed ID: 24870781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.
    Middeldorp A; Jagmohan-Changur S; van Eijk R; Tops C; Devilee P; Vasen HF; Hes FJ; Houlston R; Tomlinson I; Houwing-Duistermaat JJ; Wijnen JT; Morreau H; van Wezel T
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3062-7. PubMed ID: 19843678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDH1 rs9929218 variant at 16q22.1 contributes to colorectal cancer susceptibility.
    Han P; Liu G; Lu X; Cao M; Yan Y; Zou J; Li X; Wang G
    Oncotarget; 2016 Jul; 7(30):47278-47286. PubMed ID: 27259261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between the CDH1-472delA and -160C>A polymorphisms and diffuse and intestinal gastric cancer in a Mexican population.
    Bustos-Carpinteyro AR; Delgado-Figueroa N; Santiago-Luna E; Magaña-Torres MT; Sánchez-López JY
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive evaluation of the impact of 14 genetic variants on colorectal cancer phenotype and risk.
    Lubbe SJ; Di Bernardo MC; Broderick P; Chandler I; Houlston RS
    Am J Epidemiol; 2012 Jan; 175(1):1-10. PubMed ID: 22156018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.
    Chen B; Zhou Y; Yang P; Liu L; Qin XP; Wu XT
    Cytokine; 2011 Aug; 55(2):266-73. PubMed ID: 21570316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of E-cadherin (CDH1) Gene Polymorphism and Its Association with Cervical Cancer Risk in Bangladeshi Women.
    Rahman MA; Hasan MM; Hossain A; Alam KM; Sultana R; Mazid MA; Rahman MM
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2361-2368. PubMed ID: 37505767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CDH1 -160C/A polymorphism is associated with breast cancer: evidence from a meta-analysis.
    Ma YY; Wu WQ; Liu ZC; Yu XF; Guo K; He QW; Jiang SB; Shao QS; Tao HQ; Huang DS
    World J Surg Oncol; 2016 Jun; 14(1):169. PubMed ID: 27349965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The -160C>a polymorphism in E-cadherin is associated with the risk of nephrolithiasis.
    Tan M; Xia S; Zhang Q; Zhu J; Bao E
    PLoS One; 2013; 8(9):e73109. PubMed ID: 24023817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
    Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
    Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of Association between the CDH1 -160C>A Polymorphism and Risk of Gastrointestinal Cancer - a Meta-Analysis.
    Sahami-Fard MH; Yazd EF; Khazaei Z; Neamatzadeh H
    Asian Pac J Cancer Prev; 2016; 17(5):2415-21. PubMed ID: 27268607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population.
    Zhao L; Wang YX; Xi M; Liu SL; Zhang P; Luo LL; Liu MZ
    Int J Clin Exp Pathol; 2015; 8(5):5753-60. PubMed ID: 26191293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
    Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
    Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?
    Win AK; Hopper JL; Buchanan DD; Young JP; Tenesa A; Dowty JG; Giles GG; Goldblatt J; Winship I; Boussioutas A; Young GP; Parry S; Baron JA; Duggan D; Gallinger S; Newcomb PA; Haile RW; Le Marchand L; Lindor NM; Jenkins MA
    Eur J Cancer; 2013 May; 49(7):1578-87. PubMed ID: 23434150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.
    Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
    Endocrine; 2012 Jun; 41(3):526-31. PubMed ID: 22194161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations.
    He J; Wilkens LR; Stram DO; Kolonel LN; Henderson BE; Wu AH; Le Marchand L; Haiman CA
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):70-81. PubMed ID: 21071539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.
    Jonsson BA; Adami HO; Hägglund M; Bergh A; Göransson I; Stattin P; Wiklund F; Grönberg H
    Int J Cancer; 2004 Apr; 109(3):348-52. PubMed ID: 14961571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer.
    Timofeeva MN; Kinnersley B; Farrington SM; Whiffin N; Palles C; Svinti V; Lloyd A; Gorman M; Ooi LY; Hosking F; Barclay E; Zgaga L; Dobbins S; Martin L; Theodoratou E; Broderick P; Tenesa A; Smillie C; Grimes G; Hayward C; Campbell A; Porteous D; Deary IJ; Harris SE; Northwood EL; Barrett JH; Smith G; Wolf R; Forman D; Morreau H; Ruano D; Tops C; Wijnen J; Schrumpf M; Boot A; Vasen HF; Hes FJ; van Wezel T; Franke A; Lieb W; Schafmayer C; Hampe J; Buch S; Propping P; Hemminki K; Försti A; Westers H; Hofstra R; Pinheiro M; Pinto C; Teixeira M; Ruiz-Ponte C; Fernández-Rozadilla C; Carracedo A; Castells A; Castellví-Bel S; Campbell H; Bishop DT; Tomlinson IP; Dunlop MG; Houlston RS
    Sci Rep; 2015 Nov; 5():16286. PubMed ID: 26553438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.